Inovio Pharmaceuticals (INO) Posts Narrwer than Expected Q4 Loss; Revs Light
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.12 +1.82%
EPS Growth %: +60.7%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: +60.7%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- S&T Bancorp, Inc. to Host Second Quarter Earnings Conference Call and Webcast
- EQB completes PC Financial acquisition from Loblaw for $234.5M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
